<SEC-DOCUMENT>0001193125-26-249951.txt : 20260601
<SEC-HEADER>0001193125-26-249951.hdr.sgml : 20260601
<ACCEPTANCE-DATETIME>20260601085121
ACCESSION NUMBER:		0001193125-26-249951
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260531
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260601
DATE AS OF CHANGE:		20260601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edgewise Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001710072
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				821725586
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40236
		FILM NUMBER:		261047513

	BUSINESS ADDRESS:	
		STREET 1:		1715 38TH ST
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		720-262-7002

	MAIL ADDRESS:	
		STREET 1:		1715 38TH ST
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d24037d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ewtx="http://edgewisetx.com/20260531" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-271">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-05-31_to_2026-05-31">0001710072</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="ewtx-20260531.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-05-31_to_2026-05-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001710072</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-05-31</xbrli:startDate> <xbrli:endDate>2026-05-31</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-282">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt:datemonthdayyearen" id="ixv-283">May 31, 2026</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-284">Edgewise Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:stateprovnameen" id="ixv-285">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-286">001-40236</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-287">82-1725586</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-288">1715 38th St.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-289">Boulder</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-290">CO</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-291">80301</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices, including zip code)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-292">(720)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-293">262-7002</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:boolballotbox" id="ixv-294">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:boolballotbox" id="ixv-295">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:boolballotbox" id="ixv-296">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:boolballotbox" id="ixv-297">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-298">Class A common stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-299">EWTX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:exchnameen" id="ixv-300">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span> Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-05-31_to_2026-05-31" format="ixt-sec:boolballotbox" id="ixv-301">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;1, 2026, Edgewise Therapeutics, Inc., (the &#8220;Company&#8221;) announced its entry into an Asset Purchase Agreement (the &#8220;Agreement&#8221;) with Servier Pharmaceuticals LLC and Les Laboratoires Servier (together, the &#8220;Buyers&#8221;) on May&#160;31, 2026. A copy of the press release announcing the transaction is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> The Agreement provides that, subject to the satisfaction or waiver of certain conditions, the Buyers will acquire the sevasemten compound (&#8220;Sevasemten&#8221;) and certain other related assets (the &#8220;Purchased Assets&#8221;) collectively constituting the Company&#8217;s neuromuscular program (the &#8220;Program&#8221;) and assume certain liabilities of the Program from the Company (the &#8220;Transaction&#8221;) for: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$1.55&#160;billion in cash, payable at closing (net of certain amounts placed into escrow); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a potential milestone payment upon achieving U.S. marketing approval for Sevasemten for Becker Muscular Dystrophy in the amount of (i) $200&#160;million, in cash, payable in the event of an approved labelling including specified adult and adolescent populations or (ii)&#160;$100&#160;million in cash, payable in the event of an approved labelling including only specified adult populations (if (i)&#160;has not previously been achieved); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a potential milestone payment of $600&#160;million in cash, payable upon the achievement of U.S. marketing approval for Sevasemten for Duchenne Muscular Dystrophy; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a potential milestone payment of $300&#160;million in cash, payable upon the achievement of annual U.S. net sales of Sevasemten products exceeding $550&#160;million. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Transaction, the Buyers will make offers of employment to certain employees of the Company who primarily support the Program on terms that are comparable to those currently in effect for such employees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Agreement contains certain representations, warranties and covenants of each of the Company and the Buyers, including covenants by the Company relating to the operation of the Program prior to the closing. The Buyers have obtained &#8220;representation and warranty&#8221; insurance, which provides coverage for certain breaches of representations and warranties by the Company, subject to a deductible and certain other terms and conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Buyers and the Company have agreed to indemnify the other for certain losses arising out of breaches of representations and covenants and for certain losses arising out of excluded liabilities or assumed liabilities, as applicable, subject to customary limitations, and other matters specified in the Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consummation of the Transaction is subject to the satisfaction of customary closing conditions, including the termination or expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the absence of any law or order restraining, enjoining or otherwise making illegal the consummation of the closing. Each party&#8217;s obligation to consummate the Transaction is also subject to the accuracy of the other party&#8217;s representations and warranties contained in the Agreement (subject, with specified exceptions, to customary materiality standards) and the other party&#8217;s performance of its covenants and agreements in all material respects. The Buyers&#8217; obligation to consummate the Transaction is also subject to a condition that, since the date of the Agreement, there has not been a &#8220;Material Adverse Effect,&#8221; as defined in the Agreement. The parties have agreed to certain efforts obligations to promptly obtain the antitrust approvals required for the Transaction. The Company expects to close the Transaction in Q3&#160;2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Agreement provides termination rights for the Buyers and the Company under certain circumstances, including, subject to certain conditions, an uncured material breach by the other party or if the Transaction is not consummated by September&#160;30, 2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which will be attached to the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarter ended June&#160;30, 2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Transaction, the parties will also enter into a transition services agreement and certain other ancillary agreements at the closing. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:98.5%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Exhibit Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d24037dex991.htm">Press Release, dated June&#160;1, 2026. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Statement Regarding Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;contains</span> forward-looking statements as that term is defined in Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. Statements in this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, statements regarding the Transaction, including the Transaction timeline and potential payments which may become owing to the Company.&#160;Words such as &#8220;expects,&#8221;, &#8220;may,&#8221; &#8220;will,&#8221; &#8220;potential&#8221; and similar expressions are intended to identify forward-looking statements.&#160;The forward-looking statements contained herein are based upon the Company&#8217;s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those projected in any forward-looking statements due to numerous risks and uncertainties, including but not limited to: uncertainties relating to the timing of the consummation of the Transaction; the possibility that any or all of the conditions to the closing of the Transaction may not be satisfied or waived, including failure to receive required regulatory approvals; the effect of the announcement or pendency of the Transaction on the Company&#8217;s ability to maintain relationships with suppliers and other business partners; and risks relating to potential diversion of management attention away from the Company&#8217;s ongoing business operations. Information regarding the foregoing and additional risks may be found in the section entitled &#8220;Risk Factors&#8221; in documents that the Company files from time to time with the U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date of this Current Report on <span style="white-space:nowrap">Form&#160;8-K,</span> and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signatures </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0">


<tr>

<td style="width:13%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:86%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">EDGEWISE THERAPEUTICS, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Nofi</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Michael Nofi</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: June&#160;1, 2026 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d24037dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g24037g0601080555279.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>NEWS RELEASE</B></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on
Cardiovascular Pipeline </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#8212; Edgewise to Receive <I>$1.55 Billion in Upfront Cash Consideration and is Eligible to Receive up to
$1.1 Billion in Regulatory and Commercial Milestones &#8212;</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#8212; <I>Transaction Creates Focused Cardiovascular Company with
Enhanced Strategic Clarity &#8212; </I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#8212; <I>Upfront Proceeds Expected to Fully Fund <FONT STYLE="white-space:nowrap">EDG-7500</FONT>
Development Through Potential Approval &#8212;</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#8212; On Track to Report <FONT STYLE="white-space:nowrap">12-Week</FONT> <FONT
STYLE="white-space:nowrap">CIRRUS-HCM</FONT> Part D Data in Q2 2026 &#8212; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BOULDER, Colo.,</B> [<I>June</I><I></I><I>&nbsp;1, 2026</I>] &#8212;
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that it has entered into a definitive agreement under which Servier, an independent international pharmaceutical group governed by a
foundation, will acquire sevasemten and Edgewise&#8217;s muscular dystrophy business for $1.55&nbsp;billion in upfront cash consideration and up to $1.1&nbsp;billion in additional milestone payments, for aggregate potential consideration of up to
$2.65&nbsp;billion. The transaction meaningfully strengthens Edgewise&#8217;s balance sheet, providing enhanced financial flexibility and sharpening the Company&#8217;s strategic focus to accelerate and unlock the full potential of its
cardiovascular pipeline. Following the closing of the transaction, Edgewise will become a cardiovascular focused company, with a pipeline comprising <FONT STYLE="white-space:nowrap">EDG-7500</FONT> for hypertrophic cardiomyopathy, <FONT
STYLE="white-space:nowrap">EDG-15400</FONT> for HFpEF and <FONT STYLE="white-space:nowrap">EDG-003</FONT> for an undisclosed target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of
the agreement, Servier will acquire all rights to sevasemten, including related intellectual property, <FONT STYLE="white-space:nowrap">know-how,</FONT> key agreements, regulatory filings, and clinical data required to operate the muscular dystrophy
business. All Edgewise employees who primarily support the muscular dystrophy business will receive a comparable offer at Servier to ensure continuity of development and future commercial execution. The transaction reflects Edgewise&#8217;s
strategic focus on advancing its cardiovascular portfolio, while positioning sevasemten with an acquirer who brings the global development, regulatory, and commercial capabilities required to fully realize sevasemten&#8217;s potential for patients.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;Servier&#8217;s focus on precision therapeutics and its dedication to rare neurological and neuromuscular diseases make them the ideal steward for
the program,&#8221; said Kevin Koch, Ph.D., President and Chief Executive Officer of Edgewise Therapeutics. &#8220;This transaction delivers immediate, significant value &#8212; including $1.55&nbsp;billion upfront &#8212; while placing sevasemten
with an acquirer that has the global scale, patient commitment, and commercial reach to maximize its potential for individuals living with Becker and Duchenne muscular dystrophy. Equally important, this transaction strengthens our balance sheet and
provides financial flexibility to advance <FONT STYLE="white-space:nowrap">EDG-7500</FONT> and <FONT STYLE="white-space:nowrap">EDG-15400</FONT> through key value-inflection points.&#8221; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g24037g0601080555279.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;Edgewise is a pioneer in muscle disease biology with a proven track record of discovering and
developing precision therapies for patients with serious neurological conditions,&#8221; said Olivier Laureau, President of Servier. &#8220;The acquisition of sevasemten and Edgewise&#8217;s muscular dystrophy business, including highly experienced
talent across research, development, regulatory, and commercial functions, provides an immediate platform to expand our portfolio into Becker and Duchenne muscular dystrophy. In line with our 2030 ambition, this positions us as a major player in
neuromuscular indications to serve more patients living with devastating rare diseases.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advancing the Cardiovascular Pipeline </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separately, the Company reaffirmed that it plans to report <FONT STYLE="white-space:nowrap">12-week</FONT> data from Part D of the <FONT
STYLE="white-space:nowrap">CIRRUS-HCM</FONT> Phase 2 trial of <FONT STYLE="white-space:nowrap">EDG-7500</FONT> in the second quarter of 2026. The <FONT STYLE="white-space:nowrap">12-week</FONT> Part D data, which will include safety,
echocardiographic, biomarker, and patient-reported outcome assessments across both oHCM and nHCM, are expected to inform the Phase 3 design, with initiation targeted for the fourth quarter of 2026. In parallel, Edgewise remains on track to initiate
a Phase 2 trial of <FONT STYLE="white-space:nowrap">EDG-15400</FONT> in heart failure with preserved ejection fraction (HFpEF), further advancing the Company&#8217;s cardiovascular pipeline. Additionally, the Company believes the upfront proceeds
from this transaction, combined with its existing cash position, will fully fund <FONT STYLE="white-space:nowrap">EDG-7500</FONT> development through potential approval and provide the financial strength to further build and expand its
cardiovascular pipeline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Centerview
Partners LLC is acting as exclusive financial advisor&nbsp;to Edgewise with Wilson Sonsini Goodrich&nbsp;&amp; Rosati serving as legal counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
transaction is subject to customary closing conditions, including expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction has been unanimously approved by the boards of directors of both
Edgewise Therapeutics and Servier. Subject to the satisfaction or waiver of customary closing conditions, Servier and Edgewise expect the transaction to close in the third quarter of 2026. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Sevasemten </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sevasemten presents a novel mechanism
of action designed to selectively limit the exaggerated muscle damage caused by the absence or loss of functional dystrophin. Sevasemten is being studied in late-stage clinical trials in Becker and Duchenne muscular dystrophy. If approved,
sevasemten would be the first therapy indicated for Becker muscular dystrophy, a rare, genetic, <FONT STYLE="white-space:nowrap">X-linked</FONT> neuromuscular disorder that predominantly affects males and for which approximately 12,000 individuals
are affected in the U.S., <FONT STYLE="white-space:nowrap">EU-5,</FONT> and Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sevasemten has demonstrated sustained disease stabilization in
clinical studies spanning more than three years of treatment. In the MESA open-label extension study, participants maintained stable North Star Ambulatory Assessment (NSAA) scores in marked contrast to the functional decline expected from Becker
natural history data. Sevasemten has maintained a favorable safety and tolerability profile, with no discontinuations or dose reductions due to adverse events. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g24037g0601080555279.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sevasemten has achieved notable regulatory milestones by securing FDA Orphan Drug Designation for the
treatment of Becker and Duchenne, Rare Pediatric Disease Designation (RPDD) for the treatment of Duchenne, and Fast Track designations for the treatment of Becker and Duchenne. Further, sevasemten secured the EMA Orphan Drug Designations for the
treatment of Becker and Duchenne. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The GRAND CANYON pivotal cohort in Becker is fully enrolled with 175 participants and powered at greater than 98% to
deliver a statistically significant difference versus placebo, with <FONT STYLE="white-space:nowrap">top-line</FONT> data expected in the fourth quarter of 2026. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Edgewise Therapeutics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edgewise Therapeutics is a
leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company&#8217;s deep expertise in muscle physiology is driving a new generation of novel therapeutics.
Sevasemten is an orally administered <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> fast skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. <FONT
STYLE="white-space:nowrap">EDG-7500</FONT> is a novel cardiac sarcomere modulator for the treatment of symptomatic hypertrophic cardiomyopathy, currently in Phase 2 clinical development. <FONT STYLE="white-space:nowrap">EDG-15400</FONT> is a novel
cardiac sarcomere modulator for the treatment of heart failure, currently in Phase 1 clinical development. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To
learn more, go to edgewisetx.com or follow us on LinkedIn, X, Facebook and Instagram. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements as that term is defined in Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the
Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, statements regarding the sale of sevasemten and
Edgewise&#8217;s muscular dystrophy business to Servier (Transaction), including the Transaction timeline and potential payments which may become owing to Edgewise; the impact and effects of the Transaction on Edgewise&#8217;s business and financial
position; Edgewise&#8217;s cash runway and use of proceeds from the Transaction; the potential of, and expectations regarding, Edgewise&#8217;s product candidates and programs, including sevasemten, <FONT STYLE="white-space:nowrap">EDG-7500,</FONT> <FONT
STYLE="white-space:nowrap">EDG-15400</FONT> and its cardiovascular programs; statements regarding Edgewise&#8217;s expectations relating to its clinical trials, including timing of data (including <FONT STYLE="white-space:nowrap">12-week</FONT> data
on the <FONT STYLE="white-space:nowrap">CIRRUS-HCM</FONT> trial and data from the GRAND CANYON trial); statements regarding sevasemten potentially being the first approved therapy for Becker; statements regarding timing of Edgewise&#8217;s
initiation of a Phase 3 trial of <FONT STYLE="white-space:nowrap">EDG-7500</FONT> in HCM and a Phase 2 trial of <FONT STYLE="white-space:nowrap">EDG-15400</FONT> in HFpEF; statements regarding Edgewise&#8217;s ability to advance its pipeline; and
statements by Edgewise&#8217;s President and Chief Executive Officer and Servier&#8217;s President.&nbsp;Words such as &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221;
&#8220;will,&#8221; &#8220;goal,&#8221; &#8220;targets,&#8221; &#8220;potential&#8221; and similar expressions are intended to identify forward-looking statements.&nbsp;The forward-looking statements contained herein are based
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g24037g0601080555279.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upon Edgewise&#8217;s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those projected in any
forward-looking statements due to numerous risks and uncertainties, including but not limited to: uncertainties relating to the timing of the consummation of the Transaction; the possibility that any or all of the conditions to the closing of the
Transaction may not be satisfied or waived, including failure to receive required regulatory approvals; the effect of the announcement or pendency of the Transaction on Edgewise&#8217;s ability to maintain relationships with suppliers and other
business partners; risks relating to potential diversion of management attention away from Edgewise&#8217;s ongoing business operations; risks associated with Edgewise&#8217;s limited operating history, its product candidates being early in
development and not having products approved for commercial sale; risks associated with Edgewise not having generated any revenue to date; Edgewise&#8217;s ability to achieve objectives relating to the discovery, development and commercialization of
its product candidates, if approved; Edgewise&#8217;s substantial dependence on the success of <FONT STYLE="white-space:nowrap">EDG-7500</FONT> and <FONT STYLE="white-space:nowrap">EDG-15400;</FONT> Edgewise&#8217;s ability to develop and
commercialize <FONT STYLE="white-space:nowrap">EDG-7500</FONT> and <FONT STYLE="white-space:nowrap">EDG-15400</FONT> and to discover, develop and commercialize other product candidates in its cardiovascular programs, including <FONT
STYLE="white-space:nowrap">EDG-003;</FONT> risks related to Edgewise&#8217;s clinical trials of its product candidates not demonstrating safety and efficacy; risks related to Edgewise&#8217;s product candidates causing serious adverse events,
toxicities or other undesirable side effects; the outcome of preclinical testing and early clinical trials not being predictive of the success of later clinical trials and the risks related to the results of Edgewise&#8217;s clinical trials not
satisfying the requirements of regulatory authorities; delays or difficulties in the enrollment and/or maintenance of patients in clinical trials; Edgewise&#8217;s need for additional capital to finance its operations; risks related to failure to
capitalize on other indications or product candidates; risks related to competition; risks relating to interim, topline and preliminary data from Edgewise&#8217;s clinical trials changing as more patient data becomes available; risks related to
failure to develop a proprietary drug discovery platform; risks related to exposure to additional risk if Edgewise develops programs in connection with other therapies; risks related to production of drugs by Edgewise&#8217;s third-party
manufacturers; risks related to changes in methods of product candidate manufacturing or formulation; risks related to not achieving adequate market acceptance; risks related to the patient population for its product candidates having a small
patient population; risks related to the regulatory approval processes of domestic and foreign authorities being lengthy, time consuming and inherently unpredictable; risks relating to disruptions at the FDA, the SEC and other government agencies;
risks relating to Edgewise&#8217;s ability to attract and retain highly skilled executive officers and employees; Edgewise&#8217;s ability to obtain and maintain intellectual property protection for its product candidates; Edgewise&#8217;s reliance
on third parties; risks related to future acquisitions or strategic partnerships; risks related to general economic and market conditions; and other risks.&nbsp;Information regarding the foregoing and additional risks may be found in the section
entitled &#8220;Risk Factors&#8221; in documents that Edgewise files from time to time with the U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date of this press release, and Edgewise assumes no
obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g24037g0601080555279.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors: </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Behrad Derakhshan, Ph.D., Chief Operating
Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>ir@edgewisetx.com </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media: </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maureen Franco, VP Corporate Communications </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>media@edgewisetx.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ewtx-20260531.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/1/2026 2:29:21 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:ewtx="http://edgewisetx.com/20260531"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://edgewisetx.com/20260531"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" namespace="http://xbrl.sec.gov/stpr/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ewtx-20260531_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ewtx-20260531_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ewtx-20260531_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/1/2026 2:29:21 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ewtx-20260531_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/1/2026 2:29:21 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ewtx-20260531.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g24037g0601080555279.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g24037g0601080555279.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  M ,L# 2(  A$! Q$!_\0
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M\\L<*$A=TC!1D]!DU^9_[8_[/_QX\:_M66VO>&(=1U#3&:W.BZC:7'EQ:8
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9'-7B,4J%*THNFIJT;/5[N[TOT6K[]+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 31, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001710072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 31,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Edgewise Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-1725586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1715 38th St.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boulder<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">262-7002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class A common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EWTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d24037d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d24037d8k.htm">d24037d8k.htm</File>
    <File>ewtx-20260531.xsd</File>
    <File>ewtx-20260531_lab.xml</File>
    <File>ewtx-20260531_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d24037d8k.htm": {
   "nsprefix": "ewtx",
   "nsuri": "http://edgewisetx.com/20260531",
   "dts": {
    "inline": {
     "local": [
      "d24037d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "ewtx-20260531.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ewtx-20260531_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ewtx-20260531_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-05-31_to_2026-05-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d24037d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-05-31_to_2026-05-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d24037d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://edgewisetx.com//20260531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-26-249951-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-249951-xbrl.zip
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M(*- W8QKK;%*;7I!)E"]\)G*%GDJ9^$ ZUZ!!#(\J^WR2(TTC_0:),?\^(U
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M[63PU 1\\C)!="&6;U6.NB<_=_\XO>J2ZU^ZE\<7W=^O3SM7F^3TK%-[/):
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M)EU-$Y-^%]<OW6ZOGJJ98Z]_ %!+ P04    " !J9L%<4HJ/,5D&  "[0P
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MDJNZ_;HA>3I7F*L_\47D3VV1?)74$I+FUKGAH N2!B$D)+\I@Y9V!K*!1HM
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M]6_TF!7>PRB839D&82,2;0P,J@T-05H)5"G,FS?-V:@: &LOC@]":8."^'6
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M-V1E>#DY,2YH=&U02P$"% ,4    " !J9L%<<.KZ'V8#  "0#   $0
M        @ %X+P  97=T>"TR,#(V,#4S,2YX<V102P$"% ,4    " !J9L%<
M4HJ/,5D&  "[0P  %0              @ $-,P  97=T>"TR,#(V,#4S,5]L
M86(N>&UL4$L! A0#%     @ :F;!7'*'X[*T!   =2H  !4
M ( !F3D  &5W='@M,C R-C U,S%?<')E+GAM;%!+!08     !0 % #X!  "
%/@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>d24037d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ewtx-20260531.xsd" xlink:type="simple"/>
    <context id="duration_2026-05-31_to_2026-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001710072</identifier>
        </entity>
        <period>
            <startDate>2026-05-31</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-271">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-05-31_to_2026-05-31"
      id="Hidden_dei_EntityCentralIndexKey">0001710072</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-282">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-283">2026-05-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-284">Edgewise Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-285">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-286">001-40236</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-287">82-1725586</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-288">1715 38th St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-289">Boulder</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-290">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-291">80301</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-292">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-293">262-7002</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-294">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-295">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-296">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-297">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-298">Class A common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-299">EWTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-300">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-05-31_to_2026-05-31" id="ixv-301">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
